Request Demo
Last update 20 Mar 2025
Human fibrinogen (Sinopharm Group Shanghai Blood Products)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Non-recombinant coagulation factor |
Synonyms- |
Target |
Action modulators |
Mechanism fibrin modulators(Fibrin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (19 Dec 2016), |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)CTR20221038
评价人纤维蛋白原治疗先天性纤维蛋白原缺乏症患者的药代动力学和有效性及安全性的单臂、开放、多中心临床研究
[Translation] A single-arm, open-label, multicenter clinical study to evaluate the pharmacokinetics, efficacy and safety of human fibrinogen in the treatment of patients with congenital fibrinogen deficiency
100 Clinical Results associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)
Login to view more data
100 Translational Medicine associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)
Login to view more data
100 Patents (Medical) associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)
Login to view more data
100 Deals associated with Human fibrinogen (Sinopharm Group Shanghai Blood Products)
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hemic and Lymphatic Diseases | China | 19 Dec 2016 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Afibrinogenemia | Phase 3 | China | 09 Sep 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free